Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Capital Expenditures (2023 - 2025)

Incannex Healthcare's Capital Expenditures history spans 3 years, with the latest figure at $4000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures changed N/A year-over-year to $4000.0; the TTM value through Dec 2025 reached $6000.0, changed N/A, while the annual FY2025 figure was $8000.0, 97.11% down from the prior year.
  • Capital Expenditures for Q4 2025 was $4000.0 at Incannex Healthcare, up from $2000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $221000.0 in Q3 2023 and bottomed at -$6000.0 in Q1 2024.
  • The 3-year median for Capital Expenditures is $3500.0 (2024), against an average of $47166.7.